Kelleher Catherine L, McFann Kim K, Johnson Ann M, Schrier Robert W
Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
Am J Hypertens. 2004 Nov;17(11 Pt 1):1029-34. doi: 10.1016/j.amjhyper.2004.06.020.
Patients with autosomal dominant polycystic kidney disease (ADPKD) often develop hypertension before any abnormalities in renal function are detected clinically. Therefore, standard screening (serum creatinine and urinalysis) of young individuals with unexplained hypertension to exclude renal parenchymal disease would rarely detect ADPKD.
Data from 516 subjects with ADPKD (217 male and 299 female), aged newbornto 55 years with a normal serum creatinine and no proteinuria based on urine dipstick, studied between 1985 and 2000, were compared with data from similar subjects from the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and NHANES IV (1999-2000) data, by gender.
There was a highly significant occurrence of hypertension in young patients with ADPKD when compared to patients aged 20 to 34 years in the U.S. population. The hypertension in patients with ADPKD occurred in the absence of abnormal renal function or abnormal urinalysis.
These data indicate that renal ultrasound screening of young hypertensive individuals (aged 20 to 34 years) should be considered when searching for causes of secondary hypertension. Identifying affected ADPKD individuals early in their disease will permit aggressive blood pressure treatment and early inhibition of the renin-angiotensin-aldosterone system, which has been shown to reverse left ventricular hypertrophy, an important cardiovascular risk factor. In the present era of renal replacement therapy, cardiovascular complications are the main cause of death in patients with ADPKD.
常染色体显性多囊肾病(ADPKD)患者在临床上检测到肾功能异常之前往往就已出现高血压。因此,对不明原因高血压的年轻个体进行标准筛查(血清肌酐和尿液分析)以排除肾实质疾病,很少能检测出ADPKD。
将1985年至2000年间研究的516例ADPKD患者(217例男性和299例女性)的数据与来自美国国家健康与营养检查调查(NHANES)III(1988 - 1994年)和NHANES IV(1999 - 2000年)中类似受试者按性别分类的数据进行比较。这些ADPKD患者年龄从新生儿到55岁,血清肌酐正常且尿试纸检测无蛋白尿。
与美国20至34岁人群中的患者相比,年轻的ADPKD患者高血压发生率非常高。ADPKD患者的高血压在肾功能或尿液分析无异常的情况下出现。
这些数据表明,在寻找继发性高血压病因时,应考虑对年轻高血压个体(20至34岁)进行肾脏超声筛查。在疾病早期识别出受影响的ADPKD个体将有助于积极进行血压治疗,并早期抑制肾素 - 血管紧张素 - 醛固酮系统,这已被证明可逆转左心室肥厚,而左心室肥厚是一个重要的心血管危险因素。在当前肾脏替代治疗时代,心血管并发症是ADPKD患者死亡的主要原因。